Predicate |
Object |
contentType |
Journal Article|Review |
endingPage |
24 |
issn |
1478-6362 1478-6354 |
issueIdentifier |
Suppl 3 |
pageRange |
S17-24 |
publicationName |
Arthritis Research & Therapy |
startingPage |
S17 |
bibliographicCitation |
Lorenz HM, Kalden JR. Perspectives for TNF-alpha-targeting therapies. Arthritis Res. 2002;4 Suppl 3():S17–24. PMID: 12110119; PMCID: PMC3240140. |
creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5d04b0cb87fdfbadf6c8f6a0d5db521b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3d41c0867edcdc81926f7aa2c2b6737b |
date |
2002-05-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
identifier |
https://pubmed.ncbi.nlm.nih.gov/12110119 https://pubmed.ncbi.nlm.nih.gov/PMC3240140 https://doi.org/10.1186/ar564 |
isPartOf |
https://portal.issn.org/resource/ISSN/1478-6362 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/30289 https://portal.issn.org/resource/ISSN/1478-6354 |
language |
English |
source |
https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/ https://scigraph.springernature.com/ |
title |
Perspectives for TNF-alpha-targeting therapies |
discusses |
http://id.nlm.nih.gov/mesh/M0027329 http://id.nlm.nih.gov/mesh/M0282056 http://id.nlm.nih.gov/mesh/M0376295 http://id.nlm.nih.gov/mesh/M0001357 http://id.nlm.nih.gov/mesh/M0022150 http://id.nlm.nih.gov/mesh/M0276736 http://id.nlm.nih.gov/mesh/M0027742 |
discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6969 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_583f03fe6fa62c1516bd5044dfcbcbf3 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID126941 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8173 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_ab9bc7ce433266ca5b4543e538aeed73 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_43f5006dcd5ab8017d0173a3341d4c81 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_23537fef22489e5f17b330896ad59bbd |